文献速递心境障碍

TrkB促进神经元分泌可溶性Siglec-2(CD22)以减轻小胶质细胞活化并缓解雄性小鼠抑郁样行为

TrkB promotes the neuronal secretion of soluble Siglec-2 (CD22) to mitigate microglial activation and alleviate depression-like behaviors in male mice.
PubMed 文献 · Mol Psychiatry · 2026-04-01

该研究在雄性慢性轻度应激(CMS)抑郁小鼠模型中发现,PSD-95与Gαi1/3表达下降损害TrkB信号,导致海马组织CD22水平降低;恢复TrkB-Gαi1/3-Akt信号或过表达CD22可抑制小胶质细胞活化、促进树突棘形成并快速缓解抑郁样症状。S-氯胺酮增加CD22表达以减轻抑郁样症状,而神经元敲低CD22不影响快速(4小时内)抗抑郁效应但削弱长效(3天内)效应;单次氟西汀未能增加CD22表达或抑制小胶质细胞活性。

要点

  • CMS雄性小鼠海马TrkB信号受损致CD22降低,恢复该信号可抑制小胶质细胞活化并快速改善抑郁样行为。
  • S-氯胺酮增加CD22表达,敲低CD22削弱其长效(3天内)而非快速(4小时内)抗抑郁效应。
  • 单次氟西汀未增加CD22表达或抑制小胶质细胞活性。

核心结论

  • 快速起效抗抑郁药通过增强TrkB诱导的神经元CD22表达与分泌,促进小胶质细胞稳态,从而发挥抗抑郁作用。

研究设计与样本

  • 研究采用雄性慢性轻度应激(CMS)小鼠抑郁模型,结合dSyn3(靶向PSD-95 PDZ3域的拟肽化合物)、CD22过表达与敲低、S-氯胺酮及氟西汀干预。

主要发现

  • 雄性CMS小鼠海马PSD-95与Gαi1/3表达降低,损害TrkB信号并减少CD22水平。
  • dSyn3恢复TrkB-Gαi1/3-Akt信号,增强CD22表达,抑制小胶质细胞活化、促进树突棘形成并快速缓解抑郁样症状。
  • 海马神经元过表达CD22足以减少雄性CMS小鼠小胶质细胞活化与抑郁样行为。
  • S-氯胺酮增加CD22表达以减轻抑郁样症状;神经元敲低CD22不影响S-氯胺酮或dSyn3的快速(4小时内)抗抑郁效应,但削弱长效(3天内)效应,表现为TST与FST持续不动及糖水偏好无改善。
  • 单次氟西汀未能增加CD22表达或抑制小胶质细胞活性。

临床怎么用

  • 提示TrkB-CD22-小胶质细胞轴可能是快速起效抗抑郁药发挥长效作用的潜在靶点。
  • dSyn3通过靶向PSD-95 PDZ3域增强BDNF-TrkB-PSD-95-Gαi1/3复合物形成与Akt-mTOR活化,为干预抑郁提供候选策略。

局限性

  • 研究仅使用雄性小鼠,结论向雌性及人类外推需谨慎。
  • 机制证据主要来自啮齿类模型,尚未在临床样本中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Microglia-neuron contacts have been shown to regulate neural network activity through the formation and elimination of synapses. The pathogenesis of major depressive disorder is accompanied by a decline in brain-derived neurotrophic factor (BDNF) signaling, associated with increased microglia activity that disrupts cognitive function. The actions of both typical and rapid-acting antidepressant drugs, which have been shown to increase BDNF signaling through the tropomyosin receptor kinase B (TrkB) receptor, decrease microglia activation and the levels of pro-inflammatory cytokines. Examining the link between BDNF signaling and the microglial pro-inflammatory response, we demonstrate that TrkB signaling elicits the neuronal secretion of CD22 (Siglec-2), a sialic acid-binding immunoglobulin-type lectin, to inhibit microglial activation and alleviate depression-like symptoms. In a male chronic mild stress (CMS) mouse model of depression decreased expression of the postsynaptic scaffolding protein PSD-95 and Gαi1/3 were found to compromise TrkB signaling leading to reduced CD22 levels in hippocampal tissue. Restoration of TrkB-Gαi1/3-Akt signaling with dSyn3, a peptidomimetic compound targeting the PDZ3 domain of PSD-95, enhanced CD22 expression to inhibit microglial activation, promote dendritic spine formation and rapidly mitigate depression-like symptoms. Furthermore, hippocampal overexpression of CD22 in neurons was sufficient to reduce microglial activation and depressive-like behaviors in male CMS mice. S-ketamine, a rapid-acting antidepressant, increased CD22 expression to mitigate depression-like symptoms. While neuronal knockdown of CD22 in the hippocampus did not significantly impair the rapid (within 4 h) antidepressant effects typically observed with S-ketamine or dSyn3 administration, strikingly, knockdown of CD22 attenuated the long-acting (within 3 days) antidepressant effects of S-ketamine or dSyn3, as evidenced by sustained immobility in the TST (tail suspension test) and FST (forced swim test), and a lack of improvement in sucrose preference. In contrast, a single dose of fluoxetine failed to increase CD22 expression or inhibit microglia activity. These results suggest that rapidly-acting anti-depressant drugs enhance TrkB-induced neuronal expression and secretion of CD22 to promote the homeostatic state of microglia required for antidepressant actions. In male depression mice, dSyn3 facilitates BDNF-induced TrkB-PSD-95-Gαi1/3 complex formation to increase Akt-mTOR activation as well as synaptic and spine density in the hippocampus. TrkB signaling increases CD22 expression and secretion from neurons blocking microglial activation in the hippocampal region of male CMS mice.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Shi X, Cai SZ, Chai JL, et al. TrkB promotes the neuronal secretion of soluble Siglec-2 (CD22) to mitigate microglial activation and alleviate depression-like behaviors in male mice. Mol Psychiatry. 2026. PMID: 41922794. doi:10.1038/s41380-026-03575-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。